Editorial
doi: 10.1002/ana.21816.
Treatment for Guillain-Barré syndrome
- PMID: 19938064
- DOI: 10.1002/ana.21816
Item in Clipboard
Editorial
Treatment for Guillain-Barré syndrome
Ann Neurol.
2009 Nov.
No abstract available
Comment on
-
Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.Ann Neurol. 2009 Nov;66(5):597-603. doi: 10.1002/ana.21737. Ann Neurol. 2009. PMID: 19938102 Clinical Trial.
Similar articles
-
[Guillain-Barré syndrome. What should be done, when the treatment appears to fail?].Rev Neurol. 2003 Oct 16-31;37(8):798-800. Rev Neurol. 2003. PMID: 14593645 Spanish. No abstract available.
-
Guillain-Barré syndrome.Lancet Neurol. 2008 Dec;7(12):1081-2; author reply 1083-5. doi: 10.1016/S1474-4422(08)70248-5. Lancet Neurol. 2008. PMID: 19007731 No abstract available.
-
Treatment of Guillain-Barré syndrome and CIDP.J Peripher Nerv Syst. 2005 Jun;10(2):113-27. doi: 10.1111/j.1085-9489.2005.0010203.x. J Peripher Nerv Syst. 2005. PMID: 15958124 Review.
-
Steroids in the Guillain-Barré syndrome: is there a therapeutic window?Neurologia. 2005 Mar;20(2):53-7. Neurologia. 2005. PMID: 15726470 No abstract available.
-
[Clinical guideline review: Guillain-barre syndrome and chronic inflammatory demyelinating polyneuropathy].Nihon Naika Gakkai Zasshi. 2002 Aug 10;91(8):2443-57. Nihon Naika Gakkai Zasshi. 2002. PMID: 12373856 Review. Japanese. No abstract available.
Cited by
-
New strategies in the management of Guillain-Barré syndrome.Clin Rev Allergy Immunol. 2014 Dec;47(3):274-88. doi: 10.1007/s12016-013-8388-5. Clin Rev Allergy Immunol. 2014. PMID: 24057598 Review.
-
IVIG treatment and prognosis in Guillain-Barré syndrome.J Clin Immunol. 2010 May;30 Suppl 1(Suppl 1):S74-8. doi: 10.1007/s10875-010-9407-4. J Clin Immunol. 2010. PMID: 20396937 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
